Preserving Innovation: World IP Day Shines a Light on Recent Wins for Consumers
With World Intellectual Property (IP) Day here, it is important to recognize recent wins for IP and its role...
CASE Op-Ed in DC Journal: Biden’s Support of the TRIPS Waiver Is the Wrong Path
January 3, 2024 Every holiday season marks a time when people are swept up in the spirit of giving....
CASE Op-Ed in Townhall.Com: House Committee Must Safeguard American Healthcare Innovation From China
April 26, 2023 If somebody stole your car, hacked your bank account, and emptied your retirement savings, your response...
CASE Op-Ed in The Daily Caller: Congress And Biden’s Regulations Made Healthcare More Expensive In 2022 — The GOP Must Fix That In 2023
January 25, 2023 Make no mistake, Congress and the Biden administration took a sledgehammer to the American healthcare system...
Next on the WTO’s Agenda: Attacking Medical Innovation, Again
October 10, 2022 With the backing of President Biden, the World Trade Organization (WTO) has taken steps to tear down...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/